NADAC acquisition cost data for SPRINTEC 28 DAY TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00555901658 | $0.1406 | 2022-12-21 | Rx |
| 00555901658 | $0.1406 | 2022-12-21 | Rx |
Generic: Norgestimate-Ethinyl Estradiol | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $700.4K | 33,135 | 7,981 | $0.4522 |
| 2020 | $798.2K | 32,202 | 7,493 | $0.4998 |
| 2021 | $581.7K | 26,081 | 6,259 | $0.4574 |
| 2022 | $487.3K | 22,763 | 5,145 | $0.4372 |
| 2023 | $438.7K | 21,168 | 4,913 | $0.4122 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Ohio | $27.0K | 1,348 | 290 |
| Texas | $23.6K | 1,262 | 316 |
| Michigan | $23.0K | 1,038 | 241 |
| California | $19.6K | 716 | 209 |
| Missouri | $17.6K | 896 | 193 |
| New York | $17.2K | 727 | 170 |
| Florida | $15.6K | 809 | 180 |
| North Carolina | $14.7K | 635 | 168 |
| Pennsylvania | $14.7K | 707 | 158 |
| Indiana | $14.3K | 615 | 151 |
| Kentucky | $14.2K | 713 | 158 |
| Virginia | $13.8K | 695 | 166 |
| Oklahoma | $13.1K | 725 | 142 |
| Illinois | $12.4K | 683 | 150 |
| Minnesota | $10.8K | 447 | 119 |
| Kansas | $10.4K | 463 | 105 |
| Iowa | $10.2K | 536 | 120 |
| Washington | $10.2K | 399 | 107 |
| Georgia | $10.0K | 535 | 141 |
| Wisconsin | $9.0K | 287 | 83 |
| Tennessee | $8.7K | 420 | 90 |
| Utah | $8.4K | 351 | 98 |
| South Carolina | $8.4K | 472 | 109 |
| Arizona | $8.3K | 350 | 94 |
| Arkansas | $8.1K | 463 | 105 |
| Colorado | $8.1K | 311 | 87 |
| Oregon | $7.7K | 298 | 70 |
| Louisiana | $6.9K | 551 | 106 |
| Maine | $6.6K | 254 | 69 |
| Massachusetts | $5.7K | 255 | 65 |
| Nebraska | $5.3K | 249 | 56 |
| Alabama | $5.1K | 260 | 68 |
| Puerto Rico | $4.7K | 304 | 83 |
| Mississippi | $4.5K | 282 | 64 |
| Idaho | $4.5K | 247 | 63 |
| Maryland | $4.2K | 221 | 62 |
| New Jersey | $3.9K | 237 | 49 |
| West Virginia | $3.5K | 199 | 46 |
| New Mexico | $3.3K | 185 | 42 |
| South Dakota | $3.2K | 171 | 37 |
| Connecticut | $3.0K | 124 | 31 |
| New Hampshire | $2.9K | 125 | 31 |
| Montana | $2.3K | 99 | 25 |
| Wyoming | $2.1K | 82 | 18 |
| Nevada | $1.7K | 104 | 30 |
| Rhode Island | $1.5K | 76 | 15 |
| Alaska | $1.4K | 68 | 15 |
| North Dakota | $1.0K | 53 | N/A |
| Vermont | $992.46 | 41 | 14 |
| Delaware | $342.48 | 16 | N/A |
| Hawaii | $180.35 | 11 | N/A |
| Guam | $118.20 | 12 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.